Dengue fever infects nearly 400 million people annually. French drugmaker Sanofi spend $1.8 billion to develop the vaccine. Highly-affected areas in the Phillippines now have access to an immunization program through schools.
Manufacturers are optimistic that the vaccine could reduce infections from dengue in the Phillippines by nearly a quarter over the next five years. About 25,000 people die from dengue fever annually.
More articles on vaccines:
Mumps spread in North Dakota
After getting the boot from Tribeca Film Fest, anti-vaccination film finds new home
Seasonal flu vaccine could reduce risk of stillbirth, study suggests
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
